Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review
Background. Multiple myeloma (MM) is a chronic B-cell malignancy that involves proliferation of neoplastic clonal plasma cells in the bone marrow with circulating monoclonal immunoglobulins or constituent chains in serum or urine or both. It is a rare cancer with a lifetime risk of 0.76% and an age-...
Main Authors: | Wanjiku Gichuru, Nicholas A. O. Abinya, Andrew Odhiambo, Fredrick C. F. Otieno, Simon Harrison, Matilda Ong’ondi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2024-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2024/3208717 |
Similar Items
-
Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study
by: Angela McLigeyo, et al.
Published: (2022-02-01) -
Determinants of an integrated cervical cancer screening services in primary healthcare: sharing lessons from Kisumu, Kenya
by: Eyo Akpan, et al.
Published: (2023-05-01) -
Immunophenotypic expression profile of multiple myeloma cases at a tertiary hospital in Nairobi Kenya
by: Isabella Mengich, et al.
Published: (2023-05-01) -
Retrospective Analysis of Presentation, Treatment, and Outcomes of Multiple Myeloma at a Large Public Referral Hospital in Eldoret, Kenya
by: Kelvin M. Manyega, et al.
Published: (2021-12-01) -
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya
by: Mercy A. Oduor, et al.
Published: (2021-12-01)